ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS (PADAONCODERM)

Central Hospital, Nancy, France

Status: Unknown

Conditions: Melanoma; Oncology; Skin Lymphoma; Skin Cancer; Advance Directives; Metastatic Basal Cell Carcinoma; Skin Squamous Cell Carcinoma

Treatments: Other: no intervention, only complete a survey

Study type: Observational

Funder types: Other

Identifiers

NCT03822988

PSS-2018/PADAONCODERM

Details and patient eligibility

About

The law about advance directives is evolving but, in France, few people write it.

Te main endpoint of this research is to estimate the proportion of patients who have written their advance directives or considering doing so in onco-dermatologic population. If this rate remains low, some insights on the reasons will be able to be advanced looking at the point of view and opinion of patients about this topic.

Seconds endpoints are :

For patients against or not planning to write it, understand their reasons

Estimate the proportion of patients requesting information and understand how they would like to receive it.

Investigate a possible association between the stage of the oncological disease and the positioning of the patient concerning advance directives.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

> 18 ya

With one of the diagnoses below:

• Melanoma
• Skin lymphoma
• Meckel Carcinoma
• localy advanced or metastatic Basal cell carcinoma or squamous cell carcinoma

Exclusion criteria

Patients not in possession of all of its cognitive abilities Patients who can't read patients who don't speak french

Trial design

150 participants in 1 patient group

patients accepting to answer to the survey

Description:

patients with a skin lymphoma OR melanoma OR advanced skin squamous cell carcinoma OR advanced basal cell carcinoma accepting to answer to the anonymous survey

Treatment:

Other: no intervention, only complete a survey